Crinetics stock price target raised to $85 from $65 at Jones Trading
PositiveFinancial Markets

Crinetics Pharmaceuticals has received a significant boost in its stock price target, now set at $85, up from $65, according to Jones Trading. This increase reflects growing confidence in the company's potential and could attract more investors, signaling a positive outlook for Crinetics in the competitive pharmaceutical market.
— Curated by the World Pulse Now AI Editorial System